FDA finds another Indian drugmaker selling contaminated drugs – FiercePharma
0
“Yet another Indian drugmaker has run afoul of the FDA, this one for not doing enough to track down the source of impurities in some products and failing to investigate when customers complained about odors emanating from its APIs. The action comes as the FDA has stepped up oversight in a country that accounts for about 40% of U.S. generic and over-the-counter products.”
Read more – FiercePharma